A detailed history of Ubs Group Ag transactions in Penumbra Inc stock. As of the latest transaction made, Ubs Group Ag holds 19,235 shares of PEN stock, worth $3.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,235
Previous 14,630 31.48%
Holding current value
$3.68 Million
Previous $3.27 Million 6.0%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$172.27 - $223.95 $793,303 - $1.03 Million
4,605 Added 31.48%
19,235 $3.46 Million
Q1 2024

May 13, 2024

BUY
$220.09 - $273.15 $1.19 Million - $1.48 Million
5,414 Added 58.75%
14,630 $3.27 Million
Q4 2023

Feb 09, 2024

SELL
$181.44 - $260.22 $342,377 - $491,035
-1,887 Reduced 17.0%
9,216 $2.32 Million
Q3 2023

Nov 09, 2023

BUY
$240.69 - $338.77 $745,416 - $1.05 Million
3,097 Added 38.68%
11,103 $2.69 Million
Q2 2023

Aug 11, 2023

SELL
$271.54 - $344.06 $191,978 - $243,250
-707 Reduced 8.11%
8,006 $2.75 Million
Q1 2023

May 12, 2023

SELL
$220.43 - $278.69 $1.11 Million - $1.4 Million
-5,015 Reduced 36.53%
8,713 $2.43 Million
Q4 2022

Feb 08, 2023

SELL
$151.88 - $228.5 $563,474 - $847,735
-3,710 Reduced 21.28%
13,728 $3.05 Million
Q3 2022

Nov 10, 2022

BUY
$120.36 - $205.88 $374,801 - $641,110
3,114 Added 21.74%
17,438 $3.31 Million
Q2 2022

Aug 10, 2022

BUY
$116.09 - $227.33 $1.55 Million - $3.04 Million
13,351 Added 1372.15%
14,324 $1.78 Million
Q1 2022

May 16, 2022

SELL
$187.51 - $283.98 $781,166 - $1.18 Million
-4,166 Reduced 81.07%
973 $216,000
Q4 2021

Feb 14, 2022

BUY
$238.08 - $288.0 $966,604 - $1.17 Million
4,060 Added 376.27%
5,139 $1.48 Million
Q3 2021

Nov 15, 2021

SELL
$250.72 - $291.24 $2.62 Million - $3.04 Million
-10,449 Reduced 90.64%
1,079 $288,000
Q2 2021

Aug 13, 2021

BUY
$235.0 - $310.7 $1.25 Million - $1.66 Million
5,338 Added 86.24%
11,528 $3.16 Million
Q1 2021

May 12, 2021

BUY
$175.6 - $291.43 $661,485 - $1.1 Million
3,767 Added 155.47%
6,190 $1.68 Million
Q4 2020

Feb 11, 2021

SELL
$174.98 - $272.83 $1.89 Million - $2.95 Million
-10,797 Reduced 81.67%
2,423 $424,000
Q3 2020

Nov 12, 2020

BUY
$185.27 - $238.73 $1.94 Million - $2.5 Million
10,466 Added 380.03%
13,220 $2.57 Million
Q2 2020

Jul 31, 2020

BUY
$153.32 - $191.72 $210,815 - $263,615
1,375 Added 99.71%
2,754 $492,000
Q1 2020

May 01, 2020

SELL
$124.34 - $193.76 $2.28 Million - $3.55 Million
-18,327 Reduced 93.0%
1,379 $223,000
Q4 2019

Feb 14, 2020

BUY
$134.81 - $177.8 $2.39 Million - $3.15 Million
17,728 Added 896.26%
19,706 $3.24 Million
Q3 2019

Nov 14, 2019

SELL
$131.82 - $183.4 $82,651 - $114,991
-627 Reduced 24.07%
1,978 $266,000
Q2 2019

Aug 14, 2019

BUY
$124.65 - $167.39 $70,427 - $94,575
565 Added 27.7%
2,605 $417,000
Q1 2019

May 14, 2019

SELL
$115.84 - $160.31 $68,229 - $94,422
-589 Reduced 22.4%
2,040 $300,000
Q4 2018

Feb 14, 2019

BUY
$113.42 - $156.48 $36,294 - $50,073
320 Added 13.86%
2,629 $321,000
Q3 2018

Nov 14, 2018

SELL
$121.55 - $156.8 $590,611 - $761,891
-4,859 Reduced 67.79%
2,309 $346,000
Q2 2018

Aug 14, 2018

BUY
$112.2 - $165.95 $599,260 - $886,338
5,341 Added 292.34%
7,168 $990,000
Q1 2018

May 15, 2018

SELL
$84.6 - $126.1 $346,775 - $516,883
-4,099 Reduced 69.17%
1,827 $211,000
Q4 2017

Feb 14, 2018

SELL
$91.55 - $115.85 $238,853 - $302,252
-2,609 Reduced 30.57%
5,926 $558,000
Q3 2017

Nov 14, 2017

BUY
$79.65 - $90.3 $73,437 - $83,256
922 Added 12.11%
8,535 $771,000
Q2 2017

Aug 14, 2017

SELL
N/A
-3,877 Reduced 33.74%
7,613 $668,000
Q1 2017

Nov 14, 2017

BUY
N/A
11,490
11,490 $959,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $7.26B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.